Makary will join a major biotech firm as CEO within 12 months

Given Makary's expertise and industry connections, he is likely to secure a high-profile executive role at a biotech or pharmaceutical company within a year of leaving the FDA, leveraging his regulatory and policy experience.

Implied probability (Yes)

58%